Xencor, Inc. (XNCR)
26.08
-2.80
(-9.71%)
USD |
NASDAQ |
Aug 28, 16:00
26.05
-0.02
(-0.10%)
After-Hours: 18:13
Xencor Shareholders Equity (Quarterly) : 503.23M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 503.23M |
| March 31, 2026 | 515.63M |
| December 31, 2025 | 635.59M |
| September 30, 2025 | 625.32M |
| June 30, 2025 | 620.35M |
| March 31, 2025 | 639.87M |
| December 31, 2024 | 677.61M |
| September 30, 2024 | 723.84M |
| June 30, 2024 | 564.32M |
| March 31, 2024 | 612.53M |
| December 31, 2023 | 668.80M |
| September 30, 2023 | 669.01M |
| June 30, 2023 | 678.88M |
| March 31, 2023 | 683.58M |
| December 31, 2022 | 727.50M |
| September 30, 2022 | 722.70M |
| June 30, 2022 | 742.34M |
| March 31, 2022 | 763.02M |
| December 31, 2021 | 733.50M |
| September 30, 2021 | 618.86M |
| June 30, 2021 | 646.94M |
| March 31, 2021 | 583.61M |
| December 31, 2020 | 572.44M |
| September 30, 2020 | 568.48M |
| June 30, 2020 | 570.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 593.00M |
| December 31, 2019 | 593.20M |
| September 30, 2019 | 610.24M |
| June 30, 2019 | 608.09M |
| March 31, 2019 | 609.56M |
| December 31, 2018 | 521.68M |
| September 30, 2018 | 532.27M |
| June 30, 2018 | 519.18M |
| March 31, 2018 | 537.66M |
| December 31, 2017 | 316.46M |
| September 30, 2017 | 290.54M |
| June 30, 2017 | 301.36M |
| March 31, 2017 | 303.75M |
| December 31, 2016 | 313.95M |
| September 30, 2016 | 202.42M |
| June 30, 2016 | 208.60M |
| March 31, 2016 | 158.81M |
| December 31, 2015 | 162.43M |
| September 30, 2015 | 153.32M |
| June 30, 2015 | 162.07M |
| March 31, 2015 | 169.30M |
| December 31, 2014 | 59.29M |
| September 30, 2014 | 59.71M |
| June 30, 2014 | 65.52M |
| March 31, 2014 | 70.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 6.344B |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| MacroGenics, Inc. | 42.87M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 724.96M |
| Total Liabilities (Quarterly) | 221.73M |
| Debt to Equity Ratio | 0.338 |
| Current Ratio | 6.391 |
| Net Debt Paydown Yield | 0.87% |